A Randomized Open-Label Comparison of the Impact of Aripiprazole Versus Risperidone on Sexual Functioning (RAS Study)

被引：11
|
作者：
de Boer, Marrit K. [1 ]
Wiersma, Durk [1 ]
Bous, Johan
Sytema, Sjoerd [1 ]
van der Moolen, Andrea E. G. M. [2 ]
Wilffert, Bob [3 ]
Hamamura, Takashi [4 ]
Knegtering, Henderikus [5 ,6 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Rob Giel Res Ctr, Groningen, Netherlands
[2] Univ Groningen, Dept Med Sociol, Groningen, Netherlands
[3] Univ Groningen, Dept Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands
[4] Hamamura Clin, Kurashiki, Okayama, Japan
[5] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Neuroimaging Ctr Groningen, Groningen, Netherlands
[6] Lentis Fdn Mental Healthcare Groningen, Groningen, Netherlands
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2011年 / 31卷 / 04期
关键词：
INDUCED HYPERPROLACTINEMIA; ANTIPSYCHOTICS; OLANZAPINE; DISORDERS;
D O I：
10.1097/JCP.0b013e318222bb29
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：523 / 525
页数：3
相关论文
共 50 条
  • [21] Predictors of Early Worsening after Switch to Aripiprazole A Randomized, Controlled, Open-Label Study
    Pae, Chi-Un
    Chiesa, Alberto
    Mandelli, Laura
    Patkar, Ashwin A.
    Gibiino, Sara
    Serretti, Alessandro
    CLINICAL DRUG INVESTIGATION, 2010, 30 (03) : 187 - 193
  • [22] Aripiprazole versus olanzapine in schizophrenia: A 52-week, open-label extension study
    McQuade, R
    Kostic, D
    Marcus, R
    Carson, W
    Iwamoto, T
    Torbeyns, A
    Kerselaers, W
    Yocca, F
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S173 - S174
  • [23] An open-label study of risperidone for the treatment of agitation in dementia
    Lavretsky, H
    Sultzer, D
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1996, 4 (04): : 369 - 370
  • [24] An open-label extension study of lurasidone in patients with schizophrenia previously randomized to lurasidone or risperidone
    Mattingly, G.
    Tocco, M.
    Cucchiaro, J.
    Xu, J.
    Pikalov, A.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S559 - S559
  • [25] Open-label study of risperidone in children with bipolar disorder
    Biederman, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S314 - S314
  • [26] Effectiveness and Tolerability of Switching to Aripiprazole From Risperidone in Subjects With Autism Spectrum Disorders: A Prospective Open-Label Study
    Ishitobi, Makoto
    Kosaka, Hirotaka
    Takahashi, Tetsuya
    Yatuga, Chiho
    Asano, Mizuki
    Tanaka, Yuji
    Ueno, Kanji
    Okazaki, Ryoko
    Omori, Masao
    Hiratani, Michio
    Tomoda, Akemi
    Wada, Yuji
    CLINICAL NEUROPHARMACOLOGY, 2013, 36 (05) : 151 - 156
  • [27] Prospective, multicenter, open-label, observational study of sexual function in patients beginning aripiprazole treatment
    Montejo, A. L.
    Campos, M. C.
    Fombellida, C.
    Franco, M.
    Mellado, J. Garcia
    Urnaiz, A. Perez
    Olivares, J. M.
    Ortega, M. A.
    Prieto, N.
    Riesgo, Y.
    Barber, I.
    EUROPEAN PSYCHIATRY, 2008, 23 : S133 - S134
  • [28] Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole
    Montejo, A. L.
    Riesgo, Y.
    Luque, J.
    Barber, I.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2010, 38 (01): : 13 - 21
  • [29] Open-label study comparing the efficacy and tolerability of aripiprazole and risperidone in the treatment of children with autism spectrum disorder and ADHD
    Lamberti, M.
    Siracusano, R.
    Italiano, D.
    Guerriero, L.
    Germano, E.
    Alosi, N.
    Cucinotta, F.
    Spina, E.
    Di Rosa, G.
    Gagliano, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S200 - S201
  • [30] Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia
    Maat, A.
    Cahn, W.
    Gijsman, H. J.
    Hovens, J. E.
    Kahn, R. S.
    Aleman, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S202 - S203
12345